Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jung, Hoyong | - |
dc.contributor.author | Aman, Waciar | - |
dc.contributor.author | Hah, Jung-Mi | - |
dc.date.accessioned | 2021-06-22T14:03:49Z | - |
dc.date.available | 2021-06-22T14:03:49Z | - |
dc.date.created | 2021-01-21 | - |
dc.date.issued | 2017-05 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/9600 | - |
dc.description.abstract | JNK3 is an emerging target for neurodegenerative diseases including AD and PD, with histological selectivity. Specifically, in AD, JNK3 is the main protein kinase for APP phosphorylation, which is an important mechanism for A beta processing, and a biomarker of Alzheimer's disease. Therefore, targeting JNK3 is a reasonable strategy for drug discovery in neurodegenerative diseases. In order to find a novel scaffold for JNK3 inhibitors, we performed 3D-QSAR modeling studies with two different JNK3 inhibitor series. The CoMFA model was obtained with a q(2) value of 0.806 and an r(2) value of 0.850. Based on CoMFA and CoMSIA models, rational design was conducted and led to a novel scaffold, N-(thiophen-2-yl)-8H-pyrazolo [1,5-a]pyrido [1,2-c]pyrimidine-10-carboxamide. (C) 2017 Elsevier Ltd. All rights reserved. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.title | Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Hah, Jung-Mi | - |
dc.identifier.doi | 10.1016/j.bmcl.2017.03.063 | - |
dc.identifier.scopusid | 2-s2.0-85016422894 | - |
dc.identifier.wosid | 000401492500013 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.27, no.10, pp.2139 - 2143 | - |
dc.relation.isPartOf | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 27 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 2139 | - |
dc.citation.endPage | 2143 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
dc.subject.keywordPlus | KINASE | - |
dc.subject.keywordAuthor | JNK3 | - |
dc.subject.keywordAuthor | 3D-QSAR | - |
dc.subject.keywordAuthor | Neurodegenerative disease | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0960894X17303074?via%3Dihub | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
55 Hanyangdeahak-ro, Sangnok-gu, Ansan, Gyeonggi-do, 15588, Korea+82-31-400-4269 sweetbrain@hanyang.ac.kr
COPYRIGHT © 2021 HANYANG UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.